| Structure | Chemical Name | CAS | MF |
|
NAP2 (Neutrophil Activating Protein 2) (Biotin) (B)
|
|
|
|
|
NAP2 (Neutrophil Activating Protein 2)
|
|
|
|
|
NAP2 (Neutrophil Activating Protein 2) (Biotin) (A)
|
|
|
|
|
NAP2 (Neutrophil Activating Protein 2) (C)
|
|
|
|
|
naoxinshu
|
|
|
|
|
NAOYANGHUA
|
|
|
|
|
NAPPA
|
|
|
|
|
Nappar5
|
|
|
|
|
NAPOLEIFERIN
|
|
|
|
|
NAPOR-3 protein
|
|
|
|
|
NAPOR-2 protein
|
|
|
|
|
NAPOR-1 protein
|
|
|
|
NAP-ouabain
|
68613-44-5
|
C37H52N6O11
|
|
|
NAP-2 Polyclonal Ab
|
|
|
|
|
NAP protein
|
|
|
|
|
NAP4 protein
|
|
|
|
|
NAP2 protein
|
|
|
|
|
NAPPYSTERILISERS
|
|
|
|
|
NAP2, Recombinant, Human (Neutrophil Activating Protein 2)
|
|
|
|
|
5''-(N-BEZYL)-2-PHENYLSPIRO[5-(1,3-DIOXANE),3''-AZETIDINE]
|
|
|
|
|
NAP2, Recombinant, Human (Neutrophil Activating Protein 2) (A)
|
|
|
|
Napsagatran
|
154397-77-0
|
C26H34N6O6S
|
|
napsamycin D
|
144379-27-1
|
C40H52N8O12S
|
|
napsamycin C
|
144379-26-0
|
C39H50N8O12S
|
|
Napsagatran
|
159668-20-9
|
C26H36N6O7S
|
|
napsamycin B
|
144408-86-6
|
C40H50N8O12S
|
|
NapsamycinA
|
126049-03-4
|
C39H48N8O12S
|
|
NAPS-Biotin dihydrochloride
|
|
C16H21Cl2N3O5S2
|
|
|
Napropamide Solution
|
|
|
|
|
Napropamide PESTANAL
|
|
|
|
Naproxen (1.0 mg/mL) in Methanol
|
|
C14H14O3
|
|
|
Napropamide (Devrinol) 100 μg/mL in Acetonitrile
|
|
|
|
|
Napropamide (Devrinol) 100 μg/mL in Methanol
|
|
|
|
|
Naproxen VETRANAL
|
|
|
|
Naprodoximine
|
57925-64-1
|
C13H14N2O2
|
|
|
Naproxen Acyl--D-glucuronide Benzyl Ester
|
|
C27H28O9
|
|
NAPROXEN METHEYL AMIDE
|
|
C15H17NO4
|
|
Naproxol
|
26159-36-4
|
C14H16O2
|
|
|
NAPROPYINE SALTS IN TOLUENE
|
|
|
|
NAPROXEN IMPURITY L
|
|
C14H14O3
|
|
NAPROXEN METHYL ESTER
|
30012-51-2
|
C15H16O3
|
|
|
NAPROXEN BP
|
|
|
|
NAPROXEN DIMETHEYL AMIDE
|
|
C16H20N2O5
|
|
NAPROXEN DIISOPROPYL AMIDE
|
134736-00-8
|
C20H27NO2
|
|
|
NaproxenSodiumUsp24
|
|
|
|
Naproxen/NaproxenSodium
|
|
C28H26NaO5
|
|
|
NaproxenBaseBp98/Usp24
|
|
|
|
Napropamide
|
15299-99-7
|
C17H21NO2
|
|
|
NAPROPAMIDE(R-ISOMER)
|
|
|
|
|
NAPROXEN , NABUMETONE
|
|
|
|
Naproxen sodium
|
26159-34-2
|
C14H13O3.Na
|
|
NAPROXEN TABLETS
|
|
C14H14O3
|
|
NAPROPAMIDE
|
41643-36-1
|
C17H21NO2
|
|
|
NAPROPAMIDE(S-ISOMER)
|
|
|
|
|
NAPROPAMIDE(RS-ISOMER)
|
|
|
|
NAPROPAMIDE
|
41643-35-0
|
C17H21NO2
|
|
|
NAPROPAMIDE,DVRINOL
|
|
|
|
naproxen nitrile
|
|
C14H11NO3
|
|
naproxen isocyanate
|
125836-70-6
|
C14H13NO2
|
|
naproxen-lysine
|
|
C20H26N2O4
|
|
|
Naprodoxime
|
|
|
|
|
N-3'a-propylphenazonyl-2-acetoxybenzamide
|
|
|
|
|
NAPROXEN BASE/SODIUM
|
|
|
|
NAPROXEN, [O-METHYL-14C]
|
|
C14H14O3
|
|
Naproxen-d3
|
958293-79-3
|
C14H14O3
|
|
NAPROANILIDE
|
52570-16-8
|
C19H17NO2
|
|
Naproxen
|
22204-53-1
|
C14H14O3
|
|
NAPROXEN METHYL ESTER
|
|
C15H16O3
|
|
Naproxen amide
|
|
C14H13NO4
|
|
|
Naproxen BP98/USP24
|
|
|
|
Naproxen quinolonic acid
|
|
C20H24O8
|
|
naproxen glucuronide
|
41945-43-1
|
C20H22O9
|
|
|
Naproxan sodium
|
|
|
|
|
Naproxin Sodium
|
|
|
|
|
NAPROXEN-N-3,5-DINITROPHENYLAMIDE
|
|
|
|
|
NaPRP5 protein
|
|
|
|
|
NaPRP4 protein
|
|
|
|
|
NAPSIN A, NAP1, Pronapsin A, NAPA, ~40kD, Goat anti-Human, WB
|
|
|
|
|
NAPSIN A
|
|
|
|
NAPTALAM
|
132-66-1
|
C18H13NO3
|
|
NAP taurine
|
57462-29-0
|
C8H9N5O5S
|
|
2,7-NAPTHALENE - DISULFONIC ACID
|
|
C10H8O6S2
|
|
2-(Napth-1-yloxy)propionic acid
|
57128-29-7
|
C13H12O3
|
|
1-(2-Napthyl)hexadecane
|
2657-43-4
|
C26H40
|
|
NAPTHALENE-1,5-DISULPHONICACID
|
|
C10H8O6S2
|
|
1-NAPTHOL-3,6-DISULPHONICACID
|
|
C10H8O7S2
|
|
|
Napthol AS Phosphate/Fast Red Violet LB Liquid Substrate for AP
|
|
|
|
NAPTHALENE POWDER
|
|
C10H8
|
|
|
NAPTHOL AS-CA
|
|
|
|
1-NAPTHYL METHANAL
|
|
C11H8O
|
|
|
2-napthylamine-3-6-8-trisulphonic acid (K acid)
|
|
|
|
2-NAPTHYLMETHYLAMINE.HCL
|
|
C11H12ClN
|
|
|
1-Napthaaldehyde
|
|
|
|
|
1,5-NAPTHTALENEDIOL
|
|
|
|
1-Hydroxynaphthalene-8-sulfonic acid
|
117-22-6
|
C10H8O4S
|
|
2-NAPTHYLAMINE-1,5-DISULFONICACID DISODIUM SALT
|
|
C10H7NNa2O6S2
|
|
|
NAPTHOL SPIRITS
|
|
|
|
NAPTHOL AS-SG
|
|
C25H20N2O3
|
|
NAPTHALENE SULFONIC ACID FORMALDEHYDE
|
577773-56-9
|
|
|
|
Napthaldehydic Acid
|
|
|